Denosumab prevents periprosthetic bone mineral density loss in the tibial metaphysis in total knee arthroplasty
Not Applicable
- Conditions
- Primary osteoarthritis of knee
- Registration Number
- JPRN-UMIN000035653
- Lead Sponsor
- Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
We exclude patients who are undergoing revision surgery, and those who had previously taken anti-osteoporotic drugs or other medications known to influence bone mineral metabolism.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We measure periprosthetic bone mineral density using dual energy X-ray absorptiometry after total knee arthroplasty for 12 months.
- Secondary Outcome Measures
Name Time Method